0001419051 false 0001419051 2022-09-19 2022-09-19 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): September 19, 2022

 

THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.

 

(Exact Name of Registrant as Specified in its Charter)

 

Nevada   000-54554   45-1226465

(State or other jurisdiction of

incorporation or organization)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification Number)

 

701 Wild Rose Lane

Elk City, Idaho 83525

 

(Address of Principal Executive Offices and Zip Code)

 

(760) 295-7208

 

(Issuer’s telephone number)

 

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock   TSOI  

OTC Markets

 

 

 

 

 

 

Item 1.01 Entry into a Material Definitive Agreement.

 

On September 19, 2022, Therapeutic Solutions International, Inc., entered into an agreement with GHS Investments, LLC (“GHS”) to purchase up to $10,000,000 of Registered Common Stock.

 

Item 9.01 Financial Statements and Exhibits.

 

Exhibit Index

 

(99.1) TSOI Securities Purchase Agreement

 

(99.2) Press release dated September 20, 2022, issued by Therapeutic Solutions International, Inc.

 

104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: September 20, 2022

 

THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.  
   
By: /s/ Timothy Dixon  
  Timothy Dixon  
  Chief Executive Officer  

 

 

 

Therapeutic Solutions (PK) (USOTC:TSOI)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Therapeutic Solutions (PK) Charts.
Therapeutic Solutions (PK) (USOTC:TSOI)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Therapeutic Solutions (PK) Charts.